MTOR and retinitis pigmentosa 1: Notably, inhibition of mTOR activity via in vivo administration of rapamycin is sufficient to recapitulate cones’ degeneration observed in the different mouse models of RP, and this phenotype can be rescued by systemic treatment of insulin [60].